FDA Approves First Generic of Popular Blood Thinner
The FDA approved the first generic versions of the powerful blood thinner Eliquis (apixaban) used to prevent stroke and other conditions.
The FDA approved the first generic versions of the powerful blood thinner Eliquis (apixaban) used to prevent stroke and other conditions.
Abstract. Patients with hemophilia A can develop antifactor antibodies to factor VIII. The incidence is ∼30%, and such patients suffer worse morbidity and
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE
ANNEXA-I, the first ever randomised controlled trial of a reversal agent for direct oral anticoagulants, was published in 2024. The trial, which randomised patients with…
ANNEXA-I, the first ever randomised controlled trial of a reversal agent for direct oral anticoagulants, was published in 2024. The trial, which randomised patients with…
Sangamo Therapeutics said on Monday that partner Pfizer has terminated their hemophilia A gene therapy co-development agreement, sending its shares down nearly 64% in extended…
Research funded by the US National Institutes of Health (NIH) will have to be made publicly available without a period of delay,1 under the agency’s…
Action The U.S. Food and Drug Administration has approved Alhemo (concizumab-mtci) for routine prophylaxis to prevent or reduce the frequency of bleeding
Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. Population: Roughly 1 in 200,000 people across ethnicities; may present…
Abstract. Adeno-associated virus (AAV)–based gene therapy is an emerging treatment for hemophilia A (HA) and hemophilia B (HB). In this systematic review a